10/06/2008
Dr. Irena Melnikova Joins the TVM Capital Boston Team as a Senior Associate
October 6, 2008, Boston, MA – Dr. Irena Melnikova recently joined the TVM Capital Life Science Team in Boston as a Senior Associate to assist the Life Science Team with US-based investments and due diligence.
“Irena is a wonderful addition to the life science investing team in Boston,” said Dr. Helmut Schühsler, managing partner of TVM Capital. “Irena enhances our already scientifically strong team that has worked with companies like Sirtris and Pharmasset to help them become significant players in the biotechnology industry.”
Prior to joining TVM Capital, Dr. Melnikova launched and produced “Future in Focus,” a series of syndicated reports for Leerink Swann and was a member of the biopharma investment banking team where she supported due diligence and opportunity assessment activities that resulted in public and private financings as well as M&A transactions.
Dr. Melnikova has held positions at Life Science Insights, a subsidiary of IDC, the leading technology market research company as a research manager and as a project leader at TransForm Pharmaceuticals (acquired by Johnson & Johnson) where she was responsible for running several programs including Engineered Tissue Constructs and Amyloidoses.
She holds a Ph. D. in Molecular Medicine/Molecular Biology from the University of Texas and an MS with Honors in Chemical Engineering from Russian University of Chemical Technology. In addition, Dr. Melnikova is a regular contributor to the “Analyst Couch” section of Nature Reviews in Drug Discovery magazine and is the co-inventor on a filed patent for methods for identifying conditions affecting a cell state.
Press Contact
Monika Schlesinger
TVM Capital GmbH
Maximilianstr. 35, Eingang C
D- 80539 Munich, Germany
++49 (89) 998 992-0
Nancy Saucier
TVM Capital
101 Arch Street, Suite 1950
Boston, MA 02110, USA
+1 (617) 345 9320
